liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Management of infections caused by respiratory syncytial virus
Univ Lund, Dept Infect Dis & Med Microbiol, Div Infect Dis, SE-22185 Lund, Sweden Dept Microbiol, Linkoping, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Clin Virol, Huddinge, Sweden Karolinska Inst, Dept Clin Pharmacol, Huddinge, Sweden Dept Paediat, Boras, Sweden Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden Staten Legmiddelskontroll, Oslo, Norway Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden Univ Lund, Dept Infect Dis, Lund, Sweden Karolinska Inst, Dept Paediat, Huddinge, Sweden Karolinska Inst, Dept Haematol, Huddinge, Sweden Dept Paediat, Lund, Sweden Swedish Inst Infect Dis Control, Solna, Sweden Gothenburg Univ, Dept Paediat, Gothenburg, Sweden Univ Uppsala Hosp, Dept Paediat, S-75185 Uppsala, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Paediat, Stockholm, Sweden Karolinska Inst, Dept Infect Dis, Huddinge, Sweden.
Univ Lund, Dept Infect Dis & Med Microbiol, Div Infect Dis, SE-22185 Lund, Sweden Dept Microbiol, Linkoping, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Clin Virol, Huddinge, Sweden Karolinska Inst, Dept Clin Pharmacol, Huddinge, Sweden Dept Paediat, Boras, Sweden Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden Staten Legmiddelskontroll, Oslo, Norway Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden Univ Lund, Dept Infect Dis, Lund, Sweden Karolinska Inst, Dept Paediat, Huddinge, Sweden Karolinska Inst, Dept Haematol, Huddinge, Sweden Dept Paediat, Lund, Sweden Swedish Inst Infect Dis Control, Solna, Sweden Gothenburg Univ, Dept Paediat, Gothenburg, Sweden Univ Uppsala Hosp, Dept Paediat, S-75185 Uppsala, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Paediat, Stockholm, Sweden Karolinska Inst, Dept Infect Dis, Huddinge, Sweden.
Univ Lund, Dept Infect Dis & Med Microbiol, Div Infect Dis, SE-22185 Lund, Sweden Dept Microbiol, Linkoping, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Clin Virol, Huddinge, Sweden Karolinska Inst, Dept Clin Pharmacol, Huddinge, Sweden Dept Paediat, Boras, Sweden Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden Staten Legmiddelskontroll, Oslo, Norway Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden Univ Lund, Dept Infect Dis, Lund, Sweden Karolinska Inst, Dept Paediat, Huddinge, Sweden Karolinska Inst, Dept Haematol, Huddinge, Sweden Dept Paediat, Lund, Sweden Swedish Inst Infect Dis Control, Solna, Sweden Gothenburg Univ, Dept Paediat, Gothenburg, Sweden Univ Uppsala Hosp, Dept Paediat, S-75185 Uppsala, Sweden Med Prod Agcy, Uppsala, Sweden Karolinska Inst, Dept Paediat, Stockholm, Sweden Karolinska Inst, Dept Infect Dis, Huddinge, Sweden.
Visa övriga samt affilieringar
2001 (Engelska)Ingår i: Scandinavian Journal of Infectious Diseases, ISSN 0036-5548, E-ISSN 1651-1980, Vol. 33, nr 5, s. 323-328Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

This is a consensus document compiled by the Medical Products Agency in Sweden and the Swedish Reference Group for Antiviral Therapy on management of respiratory syncytial virus (RSV) infections. Prophylaxis against RSV infections using palivizumab, a commercially available humanized monoclonal IgG, antibody preparation, is recommended for children <2 y of age with chronic respiratory diseases requiring continuous treatment (oxygen and/or inhalations and/or steroids) during the previous 6 months and children 6 months old who were born before gestational week 26. Ribavirin inhalation treatment may be considered in high-risk infants with clinical symptoms indicating a serious course of an RSV infection. Treatment with ribavirin in combination with intravenous polyclonal immunoglobulin should be considered in patients who have received an allogenic stem cell transplantation or organ transplantation with >1 episode of rejection treatment and who have mild or moderate RSV pneumonia. Evidence-based documentation for treatment of other groups of patients is lacking.

Ort, förlag, år, upplaga, sidor
2001. Vol. 33, nr 5, s. 323-328
Nationell ämneskategori
Medicin och hälsovetenskap
Identifikatorer
URN: urn:nbn:se:liu:diva-49212OAI: oai:DiVA.org:liu-49212DiVA, id: diva2:270108
Tillgänglig från: 2009-10-11 Skapad: 2009-10-11 Senast uppdaterad: 2017-12-12

Open Access i DiVA

Fulltext saknas i DiVA

Person

Lindroth, Margaretha

Sök vidare i DiVA

Av författaren/redaktören
Lindroth, Margaretha
Av organisationen
HälsouniversitetetMedicinsk mikrobiologi
I samma tidskrift
Scandinavian Journal of Infectious Diseases
Medicin och hälsovetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 83 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf